SCHEMBL23713530

SCHEMBL23713530

O=C(O)Oc1ccc2cc(-c3ccc(Cl)cc3C(F)(F)F)c(=O)oc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
KDM4E B2RXH2 4/20 0.50
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
GLA P06280 3/20 0.50
POLB P06746 2/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
MIF P14174 2/20 0.41
HSD11B1 P28845 1/20 0.41
HPGD P15428 3/20 0.41
ALDH1A1 P00352 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 1/20 0.41
GAA P10253 2/20 0.41
CASP1 P29466 2/20 0.41
CASP7 P55210 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18535516 0.93 GLA (0.57) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL20473358 0.85 NPC1 (0.41) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL25848460 0.82 MIF (0.62) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL18583702 0.79 MIF (0.43) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL18535493 0.78 GLA (0.67) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL18583706 0.77 CA12 (0.44) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL18583394 0.76 MIF (0.44) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL22625421 0.75 CA12 (0.42) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL20473357 0.75 CA12 (0.40) NPC1RAB9AKDM4EMEN1KMT2A
SCHEMBL23713464 0.75 CYP19A1 (0.43) NPC1RAB9AKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11078177-B2 Compounds for optically active devices MERCK PATENT GMBH (DE) 2021-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11078177-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A NPC1 2482/4885RAB9A 930/4885KDM4E 4039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.